Efficacy of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis With Severe Itch at Baseline and in Subgroups by Baseline Thresholds of Severe Itch: A Post Hoc Analysis of the JADE COMPARE and JADE DARE Clinical Trials. J of Skin [Internet]. 2024 Mar. 18 [cited 2025 May 19];8(2):s380. Available from: https://skin.dermsquared.com/skin/article/view/2691